N-(1,2-二甲基乙烯亚基二氧基磷酰)咪唑 | 57648-76-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 中文名称: N-(1,2-二甲基乙烯亚基二氧基磷酰)咪唑
• 英文名称: N-(1,2-dimethylethenylenedioxyphosphoryl)imidazole
• 英文别名: Acetoin enediol cyclophosphoimidazole；1-(4,5-dimethyl-2-oxo-2λ⁵-[1,3,2]dioxaphosphol-2-yl)-1H-imidazole；4,5-Dimethyl-2-(1'-imidazolyl)-2-oxo-1,3,2-dioxaphosphol；2-(1H-Imidazol-1-yl)-4,5-dimethyl-2H-1,3,2lambda~5~-dioxaphosphol-2-one；2-imidazol-1-yl-4,5-dimethyl-1,3,2λ5-dioxaphosphole 2-oxide
• CAS: 57648-76-7
• 化学式: C₇H₉N₂O₃P
• 分子量: 200.134
• InChiKey: XTSDWAKWBYCFFE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  53.4
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  N-(1,2-二甲基乙烯亚基二氧基磷酰)咪唑 在 盐酸 作用下， 以 苯 为溶剂， 生成 1,2-dimethylethenylene phosphorochloridate
  参考文献：
  名称：

  Acetoin Enediol Cyclophosphorochloridate

  摘要：

  DOI：

  10.1055/s-1975-23862
• 作为产物：
  描述：

  咪唑 、 1,2-dimethylethenylene phosphorochloridate 以 二氯甲烷 为溶剂， 生成 N-(1,2-二甲基乙烯亚基二氧基磷酰)咪唑
  参考文献：
  名称：

  环状烯二醇磷酸化法合成脱氧核糖四核苷酸

  摘要：

  给出了磷酸二酯合成的二（1,2-二甲基亚乙基亚乙基）焦磷酸盐方法在dG，dA，dC和dT家族中将脱氧核糖核苷转化为脱氧核糖二核苷酸的完整实验细节。作为用于将脱氧核糖二核苷酸转化为脱氧核糖四核苷酸的试剂，N-（1,2-二甲基亚乙二基二氧基磷酰基）咪唑优于相应的焦磷酸盐。

  DOI：

  10.1016/s0040-4020(01)91932-5

文献信息

• A convenient synthesis of 6-, 7-, and 8-membered cyclic phosphodiesters
  作者：Fausto Ramirez、Hikotada Tsuboi、Hiroshi Okazaki、James F. Marecek

  DOI：10.1016/0040-4039(82)80133-0

  日期：1982.1

  1,3-, 1,4-, and 1,5-Alkanediols are converted into the corresponding 6-, 7-, and 8- membered cyclic phosphodiesters in a two-step procedure utilizing N-(1,2-dimethylethylene-dioxyphosphoryl)imidazole (2̃ as the sole phosphorylating reagent.

  使用N-（1,2-二甲基乙烯-二氧基磷酰基）在两步过程中将1,3-，1,4-和1,5-链烷二醇转化为相应的6、7和8元环磷酸二酯咪唑（2̃为唯一的磷酸化试剂。
• Method for production of cephalosporin compounds
  申请人：Takeda Chemical Industries, Ltd.

  公开号：EP0074611A2

  公开（公告）日：1983-03-23

  A novel method of producing a cephalosporin compound of the formula wherein R' is a hydrogen atom or an acyl group; R is a hydrogen atom or an ester residue; the dotted line means a double bond in 2- or 3-position of the cephem ring; and R4 is a nucleophilic compound residue, or a salt thereof, directly in one step from a compound of the formula wherein R', R and the dotted line have the meanings defined above, or a salt thereof, by reacting in the presence of an organic solvent the compound [II] or a salt thereof, a nucleophilic compound or a salt thereof, and (1) a trivalent or pentavalent cyclic phosphorus compound having a partial structure of the formula wherein W is an oxygen atom, a sulfur atom or NR2; W1 is an oxygen atom, a sulfur atom or NR3; and R and R3 may be the same or different and each means a hydrogen atom or a hydrocarbon group, or a salt thereof, or (2) a reaction product of a compound having a partial structure of the formula wherein W and W' have the same meanings as defined above, or a salt thereof, with a phosphorus oxyhalide, trihalide or pentahalide.

  一种生产式如下的头孢菌素化合物的新方法 其中 R'是氢原子或酰基；R 是氢原子或酯残基；虚线表示头孢环 2 位或 3 位的双键；R4 是亲核化合物残基或其盐。 其中 R'、R 和虚线具有上文定义的含义，或其盐，通过在有机溶剂存在下，使化合物 [II] 或其盐、亲核化合物或其盐和 (1) 部分结构如式的三价或五价环状磷化合物反应而成 其中 W 是氧原子、硫原子或 NR2；W1 是氧原子、硫原子或 NR3；R 和 R3 可以相同或不同，且各指一个氢原子或一个烃基，或其盐，或 (2) 部分结构如式的化合物的反应产物 其中 W 和 W' 的含义与上述定义相同，或其盐与氧卤化磷、三卤化磷或五卤化磷的反应产物。
• 3-pyrazolo(1,5-a)pyridinium cephem compounds, their production and use
  申请人：Takeda Chemical Industries, Ltd.

  公开号：EP0164113A2

  公开（公告）日：1985-12-11

  A compound of the formula; Wherein R0 stands for hydrogen atom, nitrogencontaining heterocyclic group, acyl group or aminoprotecting group, Z stands for S, S→O, 0 or CH2, R4 stands for hydrogen atom, methoxy group or formamido group, R13 stands for hydrogen atom, methyl group, hydroxyl group or halogen atom and A stands for an optionally substituted pyrazol-2-yl group forming a fused ring at the 1,5-position or a physiologically or pharmaceutically acceptable salt or ester thereof. This compound is novel and has excellent antibacterial activity.

  式中的化合物； 其中 R0 代表氢原子、含氮杂环基团、酰基或氨基保护基团，Z 代表 S、S→O、0 或 CH2，R4 代表氢原子、甲氧基或甲酰胺基团，R13 代表氢原子、甲基、羟基或卤素原子，A 代表在 1,5 位形成融合环的任选取代的吡唑-2-基团或其生理或药学上可接受的盐或酯。 该化合物是一种新型化合物，具有出色的抗菌活性。
• Cephalosporins, process for their preparation and pharmaceutical compositions containing them
  申请人：Takeda Chemical Industries, Ltd.

  公开号：EP0229369A2

  公开（公告）日：1987-07-22

  A compound of the general formula: wherein R° is hydrogen, a nitrogen-containing heterocyclic group, an acyl group or an amino-protective group; Z is S, S→O,O or CH2; R4 is hydrogen, a methoxy or formamido; R" is hydrogen, methyl, hydroxyl or halogen; and A is an optionally substituted condensed cyclic cationic group consisting of the same or different two 5- or 6-membered nitrogen-containing heterocyclic rings sharing a C-N bond with each other, , or a salt or ester thereof. , and a process for preparing the same and a pharmaceutical composition thereof are disclosed.

  本发明公开了一种通式如下的化合物：其中 R°是氢、含氮杂环基团、酰基或氨基保护基团；Z 是 S、S→O、O 或 CH2；R4 是氢、甲氧基或甲酰胺基；R "是氢、甲基、羟基或卤素；A 是由相同或不同的两个 5 元或 6 元含氮杂环彼此共用一个 C-N 键组成的任选取代的缩合环阳离子基团、Ⅳ或其盐或酯、Ⅳ及其制备方法和药物组合物。
• Exploration of the effects of linker chain modifications on anti-HIV activities in a series of cosalane analogues
  作者：W. Marek Golebiewski、Robert F. Keyes、Mark Cushman

  DOI：10.1016/0968-0896(96)00159-9

  日期：1996.10

  The effects of linker chain modifications were investigated in a series of cosalane analogues. The modifications investigated included: (1) shortening the three-carbon linker chain between the dichlorodisalicylmethane and the cholestane moiety by one carbon atom; (2) lengthening the linker chain by one carbon; (3) hydrogenation of the double bond in the linker chain; (4) changing the point of attachment of the linker chain from C-3 to C-6; (5) insertion of a phosphate between the steroid and the linker chain. With the exception of the phosphate modification, which abolished anti-HIV activity and increased cytotoxicity, the linker chain modifications produced relatively minor changes in anti-HIV activity and increased cytotoxicity, the linker chain modifications produced relatively minor changes in anti-HIV potency. The steroid and attached linker chain of cosalane therefore appear only to provide a general lipophilic appendage for the dichlorodisalicylmethane pharmacophore.